All
mRNA Hauptbahnhof
mRNA may not be a train we necessarily all need to get onboard immediately, but we should know where the central train station is located, and what it connects us to.
Of Mice and Men and Armadillos
Science news can be just so weird, or weirdly useful, that everything else recedes as we ponder whether it is true and what consequences it might bring.
Catalent Completes Expansion of Clinical Supply Facility
Catalent has completed the expansion of its clinical supply facility located in Shanghai, China.
Eisai and BioGen Alzheimer’s Drug Shows Promising Results in Phase III Study
Results from Eisai and Biogen’s Alzheimer's treatment, lecanemab, indicated significantly slowed cognitive decline in patients relative to placebo.
Merck and BigHat BioSciences Partner on Drug Discovery Programs
Merck will use BigHat’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs.
AstraZeneca Acquires Neogene Therapeutics for $320 Million
AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.
Pfizer, Merck KGaA, and Immutep Enter into Second Clinical Trial Collaboration Agreement
The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.
Aptamer Group Opens New Facility in United Kingdom
Aptamer’s new 18,000 ft² facility will expand the company's capacity to deliver novel binders for bioprocessing, diagnostic, and drug development.
Etihad Cargo Achieves IATA CEIV Pharma Recertification for Pharmaceutical Logistics
Etihad Cargo is one of the only airlines to hold IATA CEIV Pharma certification globally.
Phase III Study for Novel Ganaplacide/Lumefantrine-SDF Combination in Adults, Children with Malaria Announced
The decision to move forward in Phase III development stems from the threat of resistance to current malaria treatment growth.
Next Step in Clinical Development of Respiratory Drug Candidate SPX-001 Confirmed
SPX-001, a respiratory drug candidate, will be submitted through a combined Clinical Trial and Ethics Committee application for further advancement in the clinical stages.
FDA Approves $3.5 Million Hemophilia B Gene Therapy
CSL’s Hemgenix (etranacogene dezaparvovec) will cost approximately $3.5 million, making it the most expensive single-use medicine in the United States.
Merck Announces $1.35 Billion Acquisition of Imago BioSciences
Merck will purchase Imago BioSciences, a biotechnology company focused on bone marrow disorders, for approximately $1.35 billion.
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement
The agreement aims to develop integrated technology for large-scale exosome production.
Ferinject Approved in China for the Treatment of Iron Deficiency in Adult Patients
NMPA has approved Ferinject in China for the treatment of iron deficiency or iron deficiency anemia.
ACS-Grade Reagents’ Database Launched
The complete online database of ACS Reagent Chemicals is now available.
MilliporeSigma Invests $286 Million in US Drug Safety Testing Capacity
The $286 million investment ability is designed to elevate MillioporeSigma’s ability to conduct biosafety testing and analytical development services.
Regeneron and Cytomx Announce $2 Billion Oncology Collaboration
The collaboration will see the companies develop investigational next-generation bispecific immunotherapies for cancer.
Gelomics and Rousselot Biomedical Announce 3D Cell Culture Kits Based on Gelatin Methacryloyl
Rousselot Biomedical will supply Gelomics with its gelatin methacryloyl, a photo cross-linkable extracellular matrix, for use in Gelomics’ LunaGel 3D Tissue Culture System.
Bio-Rad Introduces Pioneer Antibody Discovery Platform for Therapeutic Development
The Pioneer Antibody Discovery Platform is a new antibody discovery service specifically designed to develop best-in-class biologic candidates.
FDA Approves Injection Designed to Delay Onset of Type 1 Diabetes
Tzield (teplizumab-mzwv) injection is the first FDA-approved therapy designed to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older.
FDA Committee Recommends Ardelyx Kidney Disease Drug
Initially rejected in July 2021, XPHOZAH (tenapanor) won recommendations as both a monotherapy and combination treatment from FDA’s CRDAC meeting.
Biotech Startup Raises $5.4M to Develop AI-Designed Protein Machines and Cell Factories
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
Element’s New Air Treatment Testing Facility Supports Indoor Space Public Health Air Quality
Element has opened a new 7500-ft3 facility that will be used to evaluate aerosolized product efficacy for reducing airborne organisms and viral particles.
CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
Sanofi and Insilico Medicine Ink $1.2 Billion Drug Development Deal
The deal will see Sanofi use Insilico’s AI drug discovery platform to advance up to six new drug development candidates.
Indivior Acquires Opiant for $145 Million
Indivior’s acquisition of Opiant grants them access to the company’s portfolio of investigational opioid overdose reversal agent, OPNT003.
ReiThera Expands Viral Vector Production Capabilities with Opening of New Manufacturing Facility
The new facility will allow ReiThera to consolidate its competitive position as a leading CDMO specialized in viral vector production.
Avantor Opens New Distribution Center in Dublin, Ireland
Avantor is continuing its investment to support the biopharma market with the opening of its new distribution center in Dublin, Ireland.
Salipro Biotech Enters into Collaboration with Sanofi
Salipro Biotech has entered into a collaboration and license agreement with Sanofi to advance discovery programs.
